JAMA + AI Weekly Update May 3, 2025

Editor’s Picks in this week’s JAMA+ AI:

• A JAMA Perspective from authors in China and Singapore discussed key issues with DeepSeek’s rapid adoption in China’s hospitals and the potential concerns this adoption raises.
• A randomized controlled trial published in JAMA Network Open found that patients with solid tumors whose oncologists received AI-triggered notifications about genomically matched clinical trials were no more likely to enroll in RCTs than those in the control group.
• A study in JAMA Dermatology found that using 3D body photography and digital dermoscopy imaging along with regular care for high-risk melanoma patients led to more skin excisions and biopsies.